Abstract
Portal vein thrombosis refers to either thrombotic or non-thrombotic occlusion of the portal vein as well as cavernoma formation. It is known to exist in association with cirrhosis or malignancy or without any associated condition i.e. non-malignant and non-cirrhotic portal vein thrombosis. Extra Hepatic Portal Venous Obstruction (EHPVO) refers to the development of portal cavernoma in the absence of associated liver disease and is the commonest cause of non-cirrhotic portal hypertension in Asia. The main pathophysiological basis of PVT is based on the “Virchow’s triad” which comprises of venous stasis, hypercoagulability and endothelial injury. Recently, an expert consensus has proposed a new classification system for PVT based on the site, clinical presentation (acute or chronic), degree of occlusion i.e. (partial or complete) and extent (extension into the splenic or superior mesenteric veins), symptomatic or asymptomatic as well as based on the type of underlying liver disease. Anticoagulation remains the mainstay of management in acute PVT and should be administered life-long in patients with an underlying proven thrombophilia. Transjugular intrahepatic portosystemic shunt even though challenging result in recanalization in a significant proportion of treated patients. Prevention of PVT with anticoagulants in compensated cirrhotics has been suggested to prevent disease progression and improve survival. Thrombectomy and thrombolysis can be done in selected symptomatic cases with acute PVT. Shunt surgery or meso-Rex bypass operation are the definitive treatment options in patients with EHPVO who have complications of portal hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. Therapeutic approaches for portal biliopathy: A systematic review. World J Gastroenterol. 2016;22(45):9909–20. https://doi.org/10.3748/wjg.v22.i45.9909. Review. PubMed PMID: 28018098; PubMed Central PMCID: PMC5143758
Pargewar SS, Desai SN, Rajesh S, Singh VP, Arora A, Mukund A. Imaging and radiological interventions in extra-hepatic portal vein obstruction. World J Radiol. 2016;8(6):556–70.
Al Khalloufi K, Laiyemo AO. Management of rectal varices in portal hypertension. World J Hepatol. 2015;7(30):2992–8. https://doi.org/10.4254/wjh.v7.i30.2992. Review. PubMed PMID: 26730278; PubMed Central PMCID: PMC4691702
Shneider BL, de Ville de Goyet J, Leung DH, Srivastava A, Ling SC, Duché M, McKiernan P, Superina R, Squires RH, Bosch J, Groszmann R, Sarin SK, de Franchis R, Mazariegos GV. Primary prophylaxis of variceal bleeding in children and the role of Meso-Rex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology. 2016;63(4):1368–80.
Trebicka J, Strassburg CP. Etiology and complications of portal vein thrombosis. Viszeralmedizin. 2014;30(6):375–80. https://doi.org/10.1159/000369987. Review. PubMed PMID: 26288604; PubMed Central PMCID: PMC4513836
Le Roy B, Gelli M, Serji B, Memeo R, Vibert E. Portal biliopathy as a complication of extrahepatic portal hypertension: etiology, presentation and management. J Visc Surg. 2015;152(3):161–6. https://doi.org/10.1016/j.jviscsurg.2015.04.003. Review. PubMed PMID: 26025414
Wani ZA, Bhat RA, Bhadoria AS, Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: need for a new classification. Saudi J Gastroenterol. 2015;21(3):129–38. https://doi.org/10.4103/1319-3767.157550. Review. PubMed PMID: 26021771; PubMed Central PMCID: PMC4455142
Varma V, Behera A, Kaman L, Chattopadhyay S, Nundy S. Surgical management of portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4(Suppl 1):S77–84. https://doi.org/10.1016/j.jceh.2013.07.005. Review. PubMed PMID: 25755599; PubMed Central PMCID: PMC4244827
Saraswat VA, Rai P, Kumar T, Mohindra S, Dhiman RK. Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy. J Clin Exp Hepatol. 2014;4(Suppl 1):S67–76. https://doi.org/10.1016/j.jceh.2013.08.011. Review. PubMed PMID: 25755598; PubMed Central PMCID: PMC4244828
Kumar M, Saraswat VA. Natural history of portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4(Suppl 1):S62–6. https://doi.org/10.1016/j.jceh.2013.08.003. Review. PubMed PMID: 25755597; PubMed Central PMCID: PMC42448
Kalra N, Shankar S, Khandelwal N. Imaging of portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4(Suppl 1):S44–52. https://doi.org/10.1016/j.jceh.2013.07.004. Review. PubMed PMID: 25755595; PubMed Central PMCID: PMC4244824
Duseja A. Portal cavernoma cholangiopathy-clinical characteristics. J Clin Exp Hepatol. 2014;4(Suppl 1):S34–6. https://doi.org/10.1016/j.jceh.2013.05.014. Review. PubMed PMID: 25755593; PubMed Central PMCID: PMC4244822
Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014;4(Suppl1):S2–S14. https://doi.org/10.1016/j.jceh.2014.02.003. Review. PubMed PMID: 25755591; PubMed Central PMCID: PMC4274351
Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22–40. https://doi.org/10.1016/j.jceh.2014.12.008. Epub 2015 Jan 6. Review. PubMed PMID: 25941431; PubMed Central PMCID: PMC4415192
Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology. 2005;41:603–8.
Arora A, Sarin SK. Multimodality imaging of primary extrahepatic portal vein obstruction (EHPVO): what every radiologist should know. Br J Radiol. 2015;88(1052):20150008. https://doi.org/10.1259/bjr.20150008. Epub 2015 May 29. PubMed PMID: 26111208; PubMed Central PMCID: PMC4651392
Mir TA, Misgar RA, Laway BA, Shah OJ, Shah ZA, Zargar SA. Prevalence and pattern of growth abnormalities in children with extrahepatic portal vein obstruction: Response to shunt surgery. Indian J Endocrinol Metab. 2016;20(6):763–6.
Sharma M, Rameshbabu CS. Collateral pathways in portal hypertension. J Clin Exp Hepatol. 2012;2(4):338–52.
Poddar U, Borkar V. Management of extra hepatic portal venous obstruction(EHPVO): current strategies. Trop Gastroenterol. 2011;32(2):94–102. Review. PubMed PMID: 21922871
Hanif FM, Soomro GB, Akhund SN, Luck NH, Laeeq SM, Abbas Z, Hassan SM, Mubarak M. Clinical presentation of extrahepatic portal vein obstruction: 10-year experience at a tertiary care hospital in Pakistan. J Transl Int Med. 2015;3(2):74–8.
Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12:2115–9.
Pieri G, Theocharidou E, Burroughs AK. Liver in haematological disorders. Best Pract Res Clin Gastroenterol. 2013;27:513–30.
Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr. 1983;103:696–702.
Morag I, Epelman M, Daneman A, et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr. 2006;148:735–9.
Kim JH, Lee YS, Kim SH, et al. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology. 2001;219:645–50.
Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut. 2001;49:720–4.
Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–41.
Monroe DM, Hoffman M. The coagulation cascade in cirrhosis. Clin Liver Dis. 2009;13:1–9.
Kinjo N, Kawanaka H, Akahoshi T, et al. Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014;6:64–71.
Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345–8.
Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost. 2010;8:1994–2000. 380 Viszeralmedizin 2014;30:375–80
Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007;46:727–33.
Denninger MH, Chaõt Y, Casadevall N, et al. Cause of portal or he- € patic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587–91.
Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96:2364–8.
Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126–32.
Bhattacharyya M, Makharia G, Kannan M, Ahmed RPH, Gupta PK, Saxena R. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis – a study from north India. Am J Clin Pathol. 2004;121:844–7.
Turnes J, García-Pagan JC, Gonz alez M, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6:1412–7.
Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–73.
De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.
Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HLA, Leebeek FWG. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4021–8.
Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther. 2011;33:1087–103.
Qi X, Zhang C, Han G, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol. 2012;27:1036–43.
Deepak A, Punamiya S, Patel N, Parekh S, Mehta S, Shah N. Prevalence of JAK2(V617F) mutation in intra-abdominal venous thrombosis. Trop Gastroenterol. 2011;32:279–84.
Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut. 2000;46:534–9.
D’Amico M, Sammarco P, Pasta L. Thrombophilic genetic factors PAI-1, MTHFRC677T, V Leiden 506Q, and prothrombin 20210A in noncirrhotic portal vein thrombosis and Budd-Chiari syndrome in a population. Int J Vasc Med. 2013;2013:717480. https://doi.org/10.1155/2013/717480. Epub 2013 Dec 18
Qi X, De Stefano V, Wang J, et al. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol. 2013;28:432–42.
Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–7.
Poultsides GA, Lewis WC, Feld R, Walters DL, Cherry DA, Ruby ST. Portal vein thrombosis after laparoscopic colectomy: thrombolytic therapy via the superior mesenteric vein. Am Surg. 2005;71:856–60.
Bernades P, Baetz A, Levy P, Belghiti J, Menu Y, Fékété F. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci. 1992;37:340–6.
Fujita F, Lyass S, Otsuka K, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg. 2003;69:951–6.
Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992;18:353–72.
Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210–8.
Habu D, Nishiguchi S, Shiomi S, et al. Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma. Indian J Gastroenterol. 2002;21:162–3.
Zheng RQ, Kudo M, Inui K, et al. Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol. 2003;38:101–3.
Matsumoto K, Yamao K, Ohashi K, et al. Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report. Gastrointest Endosc. 2003;57:269–71.
Langnas AN, Marujo W, Stratta RJ, Wood RP, Shaw BW Jr. Vascular complications after orthotopic liver transplantation. Am J Surg. 1991;161:76–82.
Doria C, Marino IR. Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report. Int Surg. 2003;88:184–7.
Dorffel T, Wruck T, Ruckert RI, Romaniuk P, Dorffel Q, Wermke W. Vascular complications in acute pancreatitis assessed by color duplex ultrasonography. Pancreas. 2000;21:126–33.
Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83–90.
Anand AC, Sashindran VK, Mohan L. Gastrointestinal problems at high altitude. Trop Gastroenterol. 2006;27:147–53.
Sakha SH, Rafeey M, Tarzamani MK. Portal venous thrombosis after umbilical vein catheterization. Indian J Gastroenterol. 2007;26:283–4.
Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol. 2005;17:745–51.
Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51:682–9.
Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novoportal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568–74.
Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and santi coagulation. Gut. 2005;54:691–7.
Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012;265:124–32.
Englesbe MJ, Kubus J, Muhammad W, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83–90.
Van Gansbeke D, Avni EF, Delcour C, Engelholm L, Struyven J. Sonographic features of portal vein thrombosis. AJR Am J Roentgenol. 1985;144:749–52.
Shah SR, Mathur SK. Presentation and natural history of variceal bleeding in patients with portal hypertension due to extrahepatic portal venous obstruction. Indian J Gastroenterol. 2003;22(6):217–20.
Garcia-Pag an JC, Hern andez-Guerra M, Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis. 2008;28:282–92.
Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med. 1979;48:627–39.
Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464–70.
Haddad MC, Clark DC, Sharif HS, Al Shahed M, Aideyan O, Sammak BM. MR, CT, and ultrasonography of splanchnic venous thrombosis. Gastrointest Radiol. 1992;17:34–40.
Merkel C, Bolognesi M, Bellon S, et al. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. J Hepatol. 1992;15:299–303.
Ganguly S, Sarin SK, Bhatia V, Lahoti D. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology. 1995;21:1226–31.
Chawla Y, Dilawari JB. Anorectal varices – their frequency in cirrhotic and non-cirrhotic portalhypertension. Gut. 1991;32:309–11.
Chawla Y, Dilawari JB, Katariya S. Gallbladder varices in portal veinthrombosis. AJR Am J Roentgenol. 1994;162:643–5.
Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int. 2006;26:512–9.
Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol. 2009;104:885–90.
Mack CL, Superina RA, Whitington PF. Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein sthrombosis. J Pediatr. 2003;142:197–9.
Khuroo MS, Yattoo GN, Zargar SA, et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology. 1993;17:807–13.
Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13:2535–40.
Harki J, Plompen EP, van Noord D, Hoekstra J, Kuipers EJ, Janssen HL, Tjwa ET. GI ischemia in patients with portal vein thrombosis: a prospective cohort study. Gastrointest Endosc. 2016;83(3):627–36.
Bajaj JS, Bhattacharjee J, Sarin SK. Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol. 2001;16(6):641–6.
Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30(9):881–94.
Mínguez B, García-Pagán JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepaticencephalopathy. Hepatology. 2006;43:707–14.
Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol. 1991;157:293–6.
Sugiyama M, Hagi H, Atomi Y, Saito M. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging. 1997;22:434–8.
Brugge WR, Lee MJ, Kelsey PB, Schapiro RH, Warshaw AL. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc. 1996;43:561–7.
Parvey HR, Raval B, Sandler CM. Portal vein thrombosis: imaging findings. AJR Am J Roentgenol. 1994;162:77–81.
Mathieu D, Vasile N, Grenier P. Portal thrombosis: dynamic CT features and course. Radiology. 1985;154:737–41.
Chou CK, Mak CW, Tzeng WS, Chang JM. CT of small bowel ischemia. Abdom Imaging. 2004;29:18–22.
Engel brecht M, Akin O, Dixit D, Schwartz L. Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging. 2011;36:62–8.
Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology. 2010;254:154–62.
Lee EYP, Khong P-L. The value of 18F-FDG PET/contrast-enhanced CT in detection of tumor thrombus. Clin Nucl Med. 2013;38:e60–5.
Qian LJ, Zhu J, Zhuang ZG, et al. Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol. 2012;22:2178–85.
Margini C, Berzigotti A. Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113–20.
Aytekin C, Boyvat F, Kurt A, Yologlu Z, Coskun M. Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol. 2001;39(2):80.
Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:651–61.
Kercher KW, Sing RF, Watson KW, Matthews BD, LeQuire MH, Heniford BT. Transhepatic thrombolysis in acute portal vein thrombosis after laparoscopic splenectomy. Surg Laparosc Endosc Percutan Tech. 2002;12:131–6.
Blum U, Haag K, Rössle M, Ochs A, Gabelmann A, Boos S, Langer M. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153–7.
Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253–60.e1–4.
Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012;32:919–27.
Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58:1776–80.
European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL/EORTC clinical practice guidelines: management of hepatocellularcarcinoma. J Hepatol. 2012;56:908–43.
Intagliata NM, Maitland H, Northup PG, Caldwell SH. Treating thrombosis in cirrhosis patients with new oral agents: ready or not? Hepatology. 2015;61:738–9. https://doi.org/10.1002/hep.27225.
Martinez M, Tandra A, Vuppalanchi R. Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology. 2014;60:425–6. https://doi.org/10.1002/hep.26998.
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal haemorrhage in cirrhosis. Hepatology. 2007;46:922–38. https://doi.org/10.1002/hep.21907.
Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013;15:625–51. https://doi.org/10.1093/europace/eut083. PMID: 23625942
Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ. Extended use of dabigatran, warfarin, or placebo in venousthromboembolism. N Engl J Med. 2013;368:709–18. https://doi.org/10.1056/NEJMoa1113697. PMID: 23425163
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799–808. https://doi.org/10.1056/NEJMoa1302507.
Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358:2765–75. https://doi.org/10.1056/NEJMoa0800374. PMID: 18579811
Scaglione F. New oral anticoagulants: comparative pharmacology with vitamin K antagonists. Clin Pharmacokinet. 2013;52:69–82. https://doi.org/10.1007/s40262-012-0030-9. PMID: 23292752
Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension inliver cirrhosis. J Hepatol. 2011;54:78–88. https://doi.org/10.1016/j.jhep.2010.06.029. PMID: 20932597
Perarnau JM, Baju A, D’alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22:1093–8. https://doi.org/10.1097/MEG.0b013e328338d995. PMID: 20308910
Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012;10:776–83.
Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis – new insights into aetiology and management. Aliment Pharmacol Ther. 2005;21:1–9.
Brearley S, Hawker PC, Dykes PW, Keighley MR. A lethal complication of peripheral vein vasopressin infusion. Hepatogastroenterology. 1985;32:224–5.
Celinska-Cedro D, Teisseyre M, Woynarowski M, Socha P, Socha J, Ryzko J. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg. 2003;38:1008–11.
Spaander MC, Murad SD, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc. 2008;67:821–7.
Orr DW, Harrison PM, Devlin J, et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during longterm follow-up. Clin Gastroenterol Hepatol. 2007;5:80–6.
Wolff M, Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg. 2003;388:141–9.
Dasgupta R, Roberts E, Superina RA, Kim PC. Effectiveness of Rex shunt in the treatment of portal hypertension. J Pediatr Surg. 2006;41:108–12.
Krebs-Schmitt D, Briem-Richter A, Grabhorn E, et al. Effectiveness of Rex shunt in children with portal hypertension following liver transplantation or with primary portal hypertension. Pediatr Transpl. 2009;13:540–4.
Livingstone AS, Koniaris LG, Perez EA, Alvarez N, Levi JU, Hutson DG. 507 Warren-Zeppa distal splenorenal shunts: a 34-year experience. Ann Surg. 2006;243:884–92.
Sharma BC, Singh RP, Chawla YK, et al. Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension. J Gastroenterol Hepatol. 1997;12:582–4.
Query JA, Sandler AD, Sharp WJ. Use of autogenous saphenous vein as a conduit for mesenterico-left portal vein bypass. J Pediatr Surg. 2007;42:1137–40.
Kim HB, Pomposelli JJ, Lillehei CW, et al. Mesogonadal shunts for extrahepatic portal vein thrombosis and variceal hemorrhage. Liver Transpl. 2005;11:1389–94.
Doenecke A, Tsui TY, Zuelke C, et al. Pre-existent portal veinthrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transpl. 2010;24:48–55.
Lendoire J, Raffin G, Cejas N, et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford). 2007;9:352–6.
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis inadults undergoing liver transplantation: risk factors, screening, management and outcome. Transplantation. 2000;69:1873–81.
Rodriguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of non neoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012;94:1145–53.
Tao YF, Teng F, Wang ZX, et al. Liver transplant recipients with portal vein thrombosis: a single center retrospective study. Hepatobiliary Pancreat Dis Int. 2009;8:34–9.
Ni YH, Wang NC, Peng MY, Chou YY, Chang FY. Bacteroides fragilis bacteremia associated with portal vein and superior mesentery vein thrombosis secondary to antithrombin III and protein C deficiency: a case report. J Microbiol Immunol Infect. 2002;35:255–8.
Sarin SK, Bansal A, Sasan S, Nigam A. Portal-vein obstruction in children leads to growth retardation. Hepatology. 1992;15:229–33.
Mehrotra RN, Bhatia V, Dabadghao P, Yachha SK. Extrahepatic portal vein obstruction in children: anthropometry, growth hormone and insulin-like growth factor I. J Pediatri Gastroenterol Nutr. 1997;25:520–3.
Menon P, Rao KL, Bhattacharya A, Thapa BR, Chowdhary SK, Mahajan JK, et al. Extrahepatic portal hypertension: quality of life and somatic growth after surgery. Eur J Pediatr Surg. 2005;15:82–7.
Nihal N, Bapat MR, Rathi P, Shah NS, Karvat A, Abraham P, et al. Relation of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels to growth retardation in extrahepatic portal vein obstruction. Hepatol Int. 2009;3:305.
Lautz TB, Sundaram SS, Whitington PF, Keys L, Superina RA. Growth impairment in children with extrahepatic portal vein obstruction is improved by mesenterico-left portal vein bypass. J Pediatr Surg. 2009;44(11):2067–70.
Sretenović A, Perisić V, Vujović D, Opacić D, Vukadinović V, Pavićević P, Radević B. Warren shunt combined with partial splenectomy in children withextra-hepatic portal hypertension, massive splenomegaly and severe hypersplenism. Srp Arh Celok Lek. 2014;142(7-8):419–23.
Goel A, Yadav S, Saraswat V, Srivastava A, Thomas MA, Pandey CM, Rathore R, Gupta R. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction. Liver Int. 2010;30(8):1143–51.
Srivastava A, Yadav SK, Yachha SK, Thomas MA, Saraswat VA, Gupta RK. Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2011;26(6):979–86.
Jha SK, Kumar A, Sharma BC, Sarin SK. Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients. Hepatol Int. 2009;3(2):384–91.
Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086–92.
Condat B, Vilgrain V, Asselah T, et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302–8.
Umphress JL, Pecha RE, Urayama S. Biliary stricture caused by portal biliopathy: diagnosis by EUS with Doppler US. Gastrointest Endosc. 2004;60:1021–4.
Nery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou PE, Plessier A, Roulot D, Chaffaut C, Bourcier V, Trinchet JC, Valla DC, Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2015;61(2):660–7.
Cai M, Zhu K, Huang W, et al. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol. 2013;24:1808–16.
Clavien PA, Selzner M, Tuttle-Newhall JE, Harland RC, Suhocki P. Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surg. 1998;227:440–5.
Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32:1154–62.
Kumar A, Sharma P, Arora A. Review article: portal vein obstruction—epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther. 2015;41(3):276–92.
Lopera JE, Correa G, Brazzini A, et al. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg. 2002;36:1058–61.
Bauer J, Johnson S, Durham J, Ludkowski M, Trotter J, Bak T, Wachs M. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006;12:1544–51. https://doi.org/10.1002/lt.20869. PMID: 17004250
Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767–75. https://doi.org/10.1111/j.1365-2036.2006.02820.x. PMID: 16556179
Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging. 2014. https://doi.org/10.1007/s00261-014-0320-9. PMID: 25504374 [Epub ahead of print]
D’Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc. 2012;44:2603–5. https://doi.org/10.1016/j.transproceed.2012.09.050. PMID: 23146469
Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J. Short- and longterm effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846–52. https://doi.org/10.1136/gut.2010.228023. PMID: 21357252
Thomas V, Jose T, Kumar S. Natural history of bleeding after esophageal variceal eradication in patients with extrahepatic portal venous obstruction; a 20-year follow-up. Indian J Gastroenterol. 2009;28(6):206–11.
Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis. 2006;10:627–51. x
Tantemsapya N, Superina R, Wang D, Kronauer G, Whitington PF, Melin-Aldana H. Hepatic histology and morphometric measurements in idiopathic extrahepatic portal vein thrombosis in children, correlated to clinical outcome of Meso-Rex Bypass.Ann Surg. Epub 2016 Dec 30.
Sharma P, Sharma BC. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol. 2012;18(3):168–72.
El-Karaksy HM, Afifi O, Bakry A, Kader AA, Saber N. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction. World J Pediatr. 2017;13(1):70–5.
Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34.
Romano F, Caprotti R, Conti M, et al. Thrombosis of the splenoportal axis after splenectomy. Langenbecks Arch Surg. 2006;391:483–8.
Condat B, Pessine T, Helene DM, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis, increased recognition and frequent recanalisation on anticoagulant therapy. Hepatology. 2000;32:466–70.
Garcovich MZM, Ainora ME, Annicchiarico BE, Ponziani FR, Cesario V, et al. Clinical outcome of portal vein thrombosis (PVT) in cirrhotic patients: observe or treat? Hepatology. 2011;54:1261A–2A.
Chung JW, Kim GH, Lee JH, et al. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol. 2014;20:384–91.
Risso ASD, Martini S, Rizzetto M, Salizzoni M. Liver transplantation in cirrhotic patients with portal vein thrombosis: a single centre experience. Dig Liver Dis. 2014;46:e40.
Chen H, Liu L, Qi X, et al. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:82–9.
Wang Z, Jiang MS, Zhang HL, et al. Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? a randomized controlled trial. Radiology. 2016;279:943–51.
Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999–1005. https://doi.org/10.1002/lt.22105. PMID: 20677291
Sringeri R. Incidental portal vein thrombosis: does it impact the surgical outcomes following liver transplantation? Liver Transpl. 2013;19:S289.
Ravaioli M, Zanello M, Grazi GL, Ercolani G, Cescon M, DelGaudio M, Cucchetti A, Pinna AD. Portal vein thrombosis andliver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011;253:378–84. https://doi.org/10.1097/SLA.0b013e318206818b. PMID: 21183851
Acknowledgements
Disclosures: None to declare from authors.
Conflict of Interest: None to declare.
Writing assistance: None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Maiwall, R., Sarin, S.K. (2018). Extrahepatic Portal Vein Obstruction: Asian and Global Perspective. In: Berzigotti, A., Bosch, J. (eds) Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-72628-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-72628-1_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72627-4
Online ISBN: 978-3-319-72628-1
eBook Packages: MedicineMedicine (R0)